Neogenomics Inc at JPMorgan Healthcare Conference Transcript
&-
Okay. If we could just sit down. We're going to start right now. I'm going to stand, but there you go. Yeah.
Hello, everyone. Thank you for coming. My name's Zach Conte, I'm a member of the healthcare investment banking team at JPMorgan. It's my pleasure to introduce you to NeoGenomics. Today, here we have Chris Smith, CEO; we've got Jeff Sherman, CFO; Vishal Sikri, President of Advanced Diagnostics; Warren Stone, President of Clinical. And I'll hand it off.
Thanks, Zach. And for all of you, loyal investors, I appreciate you being here considering it's 7:00 AM and nothing in Michigan over Washington in the first quarter. I actually asked, could I put a slide in. Yeah, it really is a score. I hope I didn't blow it if you're not recording it, but I know it's been a long day. So appreciate you being here.
We're going to give you an update on the business and state of the business. I will say from a financial perspective, we haven't changed our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |